Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly
✍ Scribed by Xianfeng Zhou; Bin Liu; Xianghui Yu; Xiao Zha; Xizhen Zhang; Xueyun Wang; Yu Chen; Yan Chen; Yue Chen; Yaming Shan; Yinghua Jin; Yongge Wu; Junqiu Liu; Wei Kong; Jiacong Shen
- Book ID
- 108069835
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 423 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0142-9612
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A human cytomegalovirus (HCMV) glycoprotein B (gpUL55) DNA vaccine has been evaluated in BALB/c mice. Intramuscular immunization of these mice with pRc/CMV2‐gB resulted in the generation of high levels of gpUL55‐specific antibody (geometric mean titer [GMT] 1:8900) and neutralizing anti
## Abstract ## Background DNA vaccines have been shown to be an effective approach to induce antigen‐specific cellular and humoral immunity. However, the lower immune intensity in clinical trials limits the application of DNA vaccine. Here we intend to develop a new DNA vaccine based on prostate s
## Abstract ## Background CGβ is expressed not only in placenta, but also in a wide range of tumors. To study DNA vaccine based on xenogeneic CGβ for cancer immuno‐therapy, we investigated whether rhesus monkey CGβ (rmCGβ) DNA vaccine could induce protective T‐cell responses and humoral responses